Redefining the role of biomarkers in heart failure trials: expert consensus document

被引:14
|
作者
Kramer, Frank [1 ]
Sabbah, Hani N. [2 ]
Januzzi, James J. [3 ]
Zannad, Faiez [4 ,5 ]
van Tintelen, J. Peter [6 ]
Schelbert, Erik B. [7 ]
Kim, Raymond J. [8 ]
Milting, Hendrik [9 ]
Vonk, Richardus [10 ]
Neudeck, Brien [11 ]
Clark, Richard [11 ]
Witte, Klaus [12 ]
Dinh, Wilfried [1 ]
Pieske, Burkert [13 ,14 ,15 ]
Butler, Javed [16 ]
Gheorghiade, Mihai [17 ]
机构
[1] Bayer AG, Expt Med Cardiovasc Hematol, Aprather Weg 18a, D-42133 Wuppertal, Germany
[2] Henry Ford Hosp, Div Cardiovasc Med, Dept Med, 2799 West Grand Blvd, Detroit, MI 48202 USA
[3] Massachusetts Gen Hosp, Cardiol Div, Baim Inst Clin Res, Clin Trial Design, Boston, MA 02114 USA
[4] Univ Lorraine, Inserm Clin Invest Ctr 1403, CHU Nancy, Inst Lorrain Coeur & Vaisseaux CHU, Nancy, France
[5] Univ Lorraine, Nancy, France
[6] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands
[7] Univ Pittsburgh, UPMC Cardiovasc Magnet Resonance Ctr, Pittsburgh, PA USA
[8] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA
[9] Ruhr Univ, Univ Clin, Heart & Diabet Ctr NRW, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Bad Oeynhausen, Germany
[10] BAYER, Res & Clin Sci Stat, Berlin, Germany
[11] Medtron Diagnost, 8200 Coral Sea St,MVC43, Minneapolis, MN 55112 USA
[12] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England
[13] Charite, Campus Virchow Klinikum, Dept Internal Med & Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany
[14] German Heart Ctr Berlin, Dept Internal Med & Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany
[15] Berlin Inst Hlth, Kapelle Ufer 2, D-10117 Berlin, Germany
[16] SUNY Stony Brook, Hlth Sci Ctr, Div Cardiol, T-16 Room 080, Stony Brook, NY 11794 USA
[17] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 201 East Huron,Galter 3-150, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
Heart failure; Biomarker; Drug development; Medical device; Imaging; Clinical trial; EXTRACELLULAR VOLUME FRACTION; CARDIOVASCULAR MAGNETIC-RESONANCE; IDIOPATHIC DILATED CARDIOMYOPATHY; RIGHT-VENTRICULAR CARDIOMYOPATHY; REDUCED EJECTION FRACTION; DIFFERENTIATION FACTOR 15; MYOCARDIAL FIBROSIS; DEVICE DIAGNOSTICS; HISTOLOGICAL VALIDATION; DIASTOLIC DYSFUNCTION;
D O I
10.1007/s10741-017-9608-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is a growing cardiovascular disease with significant epidemiological, clinical, and societal implications and represents a high unmet need. Strong efforts are currently underway by academic and industrial researchers to develop novel treatments for heart failure. Biomarkers play an important role in patient selection and monitoring in drug trials and in clinical management. The present review gives an overview of the role of available molecular, imaging, and device-derived digital biomarkers in heart failure drug development and highlights capabilities and limitations of biomarker use in this context.
引用
收藏
页码:263 / 277
页数:15
相关论文
共 50 条
  • [41] 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure
    Bakaeen, Faisal G.
    Gaudino, Mario
    Whitman, Glenn
    Doenst, Torsten
    Ruel, Marc
    Taggart, David P.
    Stulak, John M.
    Benedetto, Umberto
    Anyanwu, Anelechi
    Chikwe, Joanna
    Bozkurt, Biykem
    Puskas, John D.
    Silvestry, Scott C.
    Velazquez, Eric
    Slaughter, Mark S.
    McCarthy, Patrick M.
    Soltesz, Edward G.
    Moon, Marc R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (03): : 829 - +
  • [42] Reassessing Phase II Heart Failure Clinical Trials Consensus Recommendations
    Butler, Javed
    Hamo, Carine E.
    Udelson, James E.
    O'Connor, Christopher
    Sabbah, Hani N.
    Metra, Marco
    Shah, Sanjiv J.
    Kitzman, Dalane W.
    Teerlink, John R.
    Bernstein, Harold S.
    Brooks, Gabriel
    Depre, Christophe
    DeSouza, Mary M.
    Dinh, Wilfried
    Donovan, Mark
    Frische-Danielson, Regina
    Frost, Robert J.
    Garza, Dahlia
    Gohring, Udo-Michael
    Hellawell, Jennifer
    Hsia, Judith
    Ishihara, Shiro
    Kay-Mugford, Patricia
    Koglin, Joerg
    Kozinn, Marc
    Larson, Christopher J.
    Mayo, Martha
    Gan, Li-Ming
    Mugnier, Pierrre
    Mushonga, Sekayi
    Roessig, Lothar
    Russo, Cesare
    Salsali, Afshin
    Satler, Carol
    Shi, Victor
    Ticho, Barry
    van der Laan, Michael
    Yancy, Clyde
    Stockbridge, Norman
    Gheorghiade, Mihai
    CIRCULATION-HEART FAILURE, 2017, 10 (04)
  • [43] ANMCO/SIC Consensus Document: cardiology networks for outpatient heart failure care
    Aspromonte, Nadia
    Gulizia, Michele Massimo
    Di Lenarda, Andrea
    Mortara, Andrea
    Battistoni, Ilaria
    De Maria, Renata
    Gabriele, Michele
    Iacoviello, Massimo
    Navazio, Alessandro
    Pini, Daniela
    Di Tano, Giuseppe
    Marini, Marco
    Ricci, Renato Pietro
    Alunni, Gianfranco
    Radini, Donatella
    Metra, Marco
    Romeo, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0D) : D89 - D101
  • [44] Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
    Bayes-Genis, Antoni
    Aimo, Alberto
    Jhund, Pardeep
    Richards, Mark
    de Boer, Rudolf A.
    Arfsten, Henrike
    Fabiani, Iacopo
    Lupon, Josep
    Anker, Stefan D.
    Gonzalez, Arantxa
    Castiglione, Vincenzo
    Metra, Marco
    Mueller, Christian
    Nunez, Julio
    Rossignol, Patrick
    Barison, Andrea
    Butler, Javed
    Teerlink, John
    Filippatos, Gerasimos
    Ponikowski, Piotr
    Vergaro, Giuseppe
    Zannad, Faiez
    Seferovic, Petar
    Rosano, Giuseppe
    Coats, Andrew J. S.
    Emdin, Michele
    Januzzi, James L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1767 - 1777
  • [45] THE PROGNOSTIC ROLE OF BIOMARKERS IN PATIENTS WITH CHRONIC HEART FAILURE
    Kurlyanskaya, Ye. K.
    Mrochek, A. G.
    Denisevich, T. L.
    Kolyadka, M. G.
    Russkikh, I. I.
    KARDIOLOGIYA, 2020, 60 (01) : 16 - 22
  • [46] Redefining heart failure: The utility of genomics
    Donahue, Mark P.
    Marchuk, Douglas A.
    Rockman, Howard A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) : 1289 - 1298
  • [47] Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
    Vaduganathan, Muthiah
    Claggett, Brian
    Packer, Milton
    McMurray, John J. V.
    Rouleau, Jean L.
    Zile, Michael R.
    Swedberg, Karl
    Solomon, Scott D.
    JACC-HEART FAILURE, 2018, 6 (07) : 564 - 569
  • [48] Redefining Heart Failure in Breast Cancer
    Volgman, Annabelle Santos
    Brezden-Masley, Christine
    Okwuosa, Tochi
    JACC: CARDIOONCOLOGY, 2022, 4 (01): : 66 - 68
  • [49] ACC expert consensus document on coronary artery stents
    Holmes, DR
    Hirshfeld, J
    Faxon, D
    Vlietstra, RE
    Jacobs, A
    King, SB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) : 1471 - 1482
  • [50] Abridged version of the expert consensus document on arterial stiffness
    Laurent S.
    Cockcroft J.
    Van Bortel L.
    Boutouyrie P.
    Giannattasio C.
    Hayoz D.
    Pannier B.
    Vlachopoulos C.
    Wilkinson I.
    Struijker-Boudier H.
    Artery Research, 2007, 1 (1) : 2 - 12